PEDIATRICS Vol. 86 No. 2 August 1990, pp. 221-225
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickson, G. B.
Right arrow Articles by Clayton, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickson, G. B.
Right arrow Articles by Clayton, E. W.

Should Promethazine in Liquid Form Be Available Without Prescription?

Gerald B. Hickson MD1, William A. Altemeier MD1, and Ellen W. Clayton MD, JD1

1 From the Department of Pediatrics, Vanderbilt University, Nashville, Tennessee

Promethazine, available by prescription only since its introduction in 1946, has been widely used for pediatric patients because of its antihistaminic, antiemetic and sedative properties. Recently, it's makers have sought Federal Drug Administration approval to introduce two liquid over the counter allergy/cold/cough products containing promethazine as an active ingredient. Although millions of doses have been administered, promethazine use has not been free of risk. Promethazine has been reported to cause significant sedation, agitation, hallucinations, seizures, dystonic reactions, and possibly apparent life-threatening events or sudden infant death syndrome. The impact of these relatively uncommon adverse reactions on children would be minimal if parents would use over the counter promethazine only for appropriate indications and only in children greater than 2 years of age. However, according to results of research evaluating the use of various over the counter medications by families for their children, promethazine will be used inappropriately. Both its over the counter status, implying a certain margin of safety, and its formulation as a syrup, providing ease of administration, should increase its use in all age groups including that by children less than 2 years of age who may be most vulnerable to the adverse reactions associated with the drug's use.

Key Words: promethazine • sudden infant death syndrome • apnea • antihistamine • child abuse

Submitted on March 27, 1989
Accepted on October 13, 1989




This article has been cited by other articles:


Home page
 NEJMHome page
P. R. Starke, J. Weaver, and B. A. Chowdhury
Boxed Warning Added to Promethazine Labeling for Pediatric Use
N. Engl. J. Med., June 23, 2005; 352(25): 2653 - 2653.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T.-Y. Ling, C.-L. Chen, Y.-H. Huang, I-H. Liu, S. S. Huang, and J. S. Huang
Identification and Characterization of the Acidic pH Binding Sites for Growth Regulatory Ligands of Low Density Lipoprotein Receptor-related Protein-1
J. Biol. Chem., September 10, 2004; 279(37): 38736 - 38748.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
K. T. Kwon, S. E. Rudkin, and M. l. Langdorf
Antiemetic Use in Pediatric Gastroenteritis: A National Survey of Emergency Physicians, Pediatricians, and Pediatric Emergency Physicians
Clinical Pediatrics, November 1, 2002; 41(9): 641 - 652.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
N. L. Antunes
Topical Review: Acute Neurologic Complications in Children With Systemic Cancer
J Child Neurol, November 1, 2000; 15(11): 705 - 716.
[Abstract] [PDF]